Mercans Unveils Strategic Innovations to Enhance Global Payroll and AI-Powered Client Experience
Seamless, data-driven, and customer-focused global payroll through advanced tech and intelligent automation.
Mercans, a global leader in payroll technology, today announced three significant developments aimed at strengthening its service offerings and enhancing client experiences: the establishment of a Payroll Compliance Center of Excellence (CoE), the integration of HiBob into its technology ecosystem, and the launch of an AI-powered Digital Sales Room (DSR).
Establishment of Payroll Compliance Center of Excellence
In response to the increasing complexity of global payroll regulations, Mercans has established a dedicated Payroll Compliance Center of Excellence. This center brings together subject-matter experts in labor laws, tax regulations, social security frameworks, and data protection policies across all regions served by Mercans.
The center is responsible for developing internal compliance benchmarks, automating statutory updates across the G2N Nova payroll engine, and ensuring clients meet all in-country compliance requirements without disruption. By proactively managing compliance, Mercans aims to minimize audit risks and ensure long-term operational continuity for multinational & enterprise clients.
Integration of HiBob into Mercans’ Technology Ecosystem
Mercans has integrated HiBob, a modern HR platform, into its technology ecosystem, making it easier than ever for businesses to connect their HR and payroll systems.
Clients already using HiBob as their HRIS can now take full advantage of Mercans’ global payroll solution. With real-time, two-way data sync between the two platforms, HR and finance teams can manage payroll across 100+ countries faster, more accurately, and with full compliance.
The integration provides instant access to live, approved employee records, delivered through a single API request per pay group and pay period in JSON format. This streamlines data exchange, reduces errors, and boosts payroll processing speed.
Joint customers also get access to the Mercans PAC portal, offering a unified experience across HR, payroll, and compliance functions, without the need for complex setups or custom builds.
This partnership ensures a consistent, compliant, and seamless employee experience across borders.
Launch of AI-Powered Digital Sales Room
Mercans has also launched its Digital Sales Room (DSR), an AI-powered, on-demand environment where prospects and clients can explore everything they need to know before choosing Mercans as their partner. The DSR includes product demos, implementation frameworks, governance and support models, SLAs, and key documentation - all in one place. Clients can also interact with a built-in AI agent to get real-time answers, making the evaluation process faster and more informed.
DSR supports clients at every step of their decision journey and with this launch, Mercans becomes the only payroll technology company to offer such an immersive, intelligent, and self-guided buying experience.
The platform is designed to reduce time-to-engagement, improve decision-making transparency, and ensure every prospective client gains a clear, data-backed understanding of how Mercans delivers payroll, EOR, SaaS, and compliance services at scale.
About Mercans
Mercans is a global payroll technology company delivering SaaS, compliance, and employer-of-record services in over 160 countries. Through its proprietary platform G2N Nova, Mercans enables automated gross-to-net calculations in seconds, providing a fully touchless and scalable payroll experience. To learn more about this innovative platform, visit www.mercans.com
LinkedIn
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250626924542/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom